CA3158393A1 - Composition de cellulose, comprime et comprime orodispersible - Google Patents

Composition de cellulose, comprime et comprime orodispersible

Info

Publication number
CA3158393A1
CA3158393A1 CA3158393A CA3158393A CA3158393A1 CA 3158393 A1 CA3158393 A1 CA 3158393A1 CA 3158393 A CA3158393 A CA 3158393A CA 3158393 A CA3158393 A CA 3158393A CA 3158393 A1 CA3158393 A1 CA 3158393A1
Authority
CA
Canada
Prior art keywords
cellulose
cellulose composition
tablet
glucose
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3158393A
Other languages
English (en)
Inventor
Tadahiro Kumagai
Yuji Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Asahi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Corp filed Critical Asahi Kasei Corp
Publication of CA3158393A1 publication Critical patent/CA3158393A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H8/00—Macromolecular compounds derived from lignocellulosic materials
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates
    • C08K5/053—Polyhydroxylic alcohols
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/15—Heterocyclic compounds having oxygen in the ring
    • C08K5/151—Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1545—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

L'invention concerne une composition de cellulose qui contient de la cellulose, du glucose et du sorbitol ; pour 5 g de la composition de cellulose, la teneur totale en glucose et en sorbitol est de 0,7 à 4,0 mg. L'invention concerne également un comprimé qui contient la composition de cellulose susmentionnée. L'invention concerne en outre un comprimé orodispersible qui contient la composition de cellulose susmentionnée.
CA3158393A 2019-11-07 2019-11-07 Composition de cellulose, comprime et comprime orodispersible Pending CA3158393A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2019/043581 WO2021090421A1 (fr) 2019-11-07 2019-11-07 Composition de cellulose, comprimé et comprimé orodispersible

Publications (1)

Publication Number Publication Date
CA3158393A1 true CA3158393A1 (fr) 2021-05-14

Family

ID=72047935

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3158393A Pending CA3158393A1 (fr) 2019-11-07 2019-11-07 Composition de cellulose, comprime et comprime orodispersible

Country Status (7)

Country Link
US (1) US20230059899A1 (fr)
EP (1) EP4056638A4 (fr)
JP (1) JP6744517B1 (fr)
CN (1) CN112770779B (fr)
BR (1) BR112022007434A2 (fr)
CA (1) CA3158393A1 (fr)
WO (1) WO2021090421A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024204699A1 (fr) * 2023-03-31 2024-10-03 旭化成株式会社 Poudre de cellulose et corps moulé

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3182404B2 (ja) * 1998-01-14 2001-07-03 大日本製薬株式会社 口腔内崩壊錠及びその製造方法
JP4438121B2 (ja) * 1998-04-27 2010-03-24 大正製薬株式会社 口腔内速崩錠及びその製造方法
JP4493769B2 (ja) * 1999-12-21 2010-06-30 旭化成ケミカルズ株式会社 球形顆粒
JP2005162841A (ja) * 2003-12-01 2005-06-23 Daicel Chem Ind Ltd 水溶性助剤及びその用途
US20100310686A1 (en) * 2007-11-14 2010-12-09 Uxmal S.A., Chile Extracts of deschampsia antarctica desv, with antineoplastic activity
WO2013180248A1 (fr) 2012-05-31 2013-12-05 旭化成ケミカルズ株式会社 Poudre de cellulose
US10292934B2 (en) * 2012-09-20 2019-05-21 Daicel Corporation Disintegrating particle composition containing acid-type carboxymethylcellulose and crystalline cellulose, and orally disintegrating tablet containing said composition
JP6104038B2 (ja) * 2013-05-02 2017-03-29 旭化成株式会社 結晶セルロースの複合組成物
CN103893141A (zh) * 2014-03-14 2014-07-02 王志刚 一种替诺昔康口腔崩解片及其制备方法
CA2988485A1 (fr) * 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Comprime orodispersible contenant de l'estetrol

Also Published As

Publication number Publication date
EP4056638A4 (fr) 2022-11-30
EP4056638A1 (fr) 2022-09-14
WO2021090421A1 (fr) 2021-05-14
US20230059899A1 (en) 2023-02-23
JPWO2021090421A1 (ja) 2021-11-25
CN112770779A (zh) 2021-05-07
CN112770779B (zh) 2022-07-22
JP6744517B1 (ja) 2020-08-19
BR112022007434A2 (pt) 2022-07-12

Similar Documents

Publication Publication Date Title
US9446137B2 (en) Composite particles which contain both cellulose and inorganic compound
JP7332549B2 (ja) マウントの発生を抑制する方法
JP7028927B2 (ja) 顆粒の静電量を低減させる方法
JP2021075686A (ja) セルロース組成物、錠剤及び口腔内崩壊錠
JP6744517B1 (ja) セルロース組成物、錠剤及び口腔内崩壊錠
WO2019130701A1 (fr) Poudre de cellulose
JP6744518B1 (ja) セルロース組成物及び錠剤
RU2796502C1 (ru) Содержащая целлюлозу композиция, таблетка и таблетка с внутриротовой распадаемостью
TWI723621B (zh) 纖維素組合物、錠劑及口腔內崩散錠
TWI734247B (zh) 纖維素組合物及錠劑
RU2798266C1 (ru) Содержащая целлюлозу композиция и таблетка
JP2021075687A (ja) セルロース組成物及び錠剤
JP2022139962A (ja) 顆粒、顆粒の製造方法、及び錠剤

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220420

EEER Examination request

Effective date: 20220420

EEER Examination request

Effective date: 20220420

EEER Examination request

Effective date: 20220420

EEER Examination request

Effective date: 20220420

EEER Examination request

Effective date: 20220420

EEER Examination request

Effective date: 20220420

EEER Examination request

Effective date: 20220420